AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22080870 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive therapy (MCT), 8 weekly intervention sessions
Number of subjects: 20
Study 22080870 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 20
Study 20411995 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists provided intensified hypertension management and drug adherence counseling
Number of subjects: 584
Study 20411995 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 584
Study 18684259 — intervention group
Group type: EXPERIMENTAL
Intervention: SVC On
Number of subjects: 42
Study 18684259 — intervention group
Group type: COMPARATOR
Intervention: SVC Off
Number of subjects: 42
Study 18684259 — intervention group
Group type: COMPARATOR
Intervention: SVC On and Off
Number of subjects: 42
Study 18684259 — intervention group
Group type: EXPERIMENTAL
Intervention: Best SVC configuration or deliberate PD programming
Number of subjects: 42
Study 15966377 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural tramadol infusion
Number of subjects: 20
Study 15966377 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tramadol infusion
Number of subjects: 20
Study 12651051 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute hyperglycemia (13.9 mmol/l, 250 mg/dl)
Number of subjects: 12
Study 12651051 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia (5.5 mmol/l, 100 mg/dl)
Number of subjects: 12
Study 10824717 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg)
Number of subjects: 10
Study 10824717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 10824717 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 10
Study 8862500 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 41
Study 8862500 — intervention group
Group type: COMPARATOR
Intervention: Premenopausal women
Number of subjects: 41
Study 1436561 — intervention group
Group type: EXPERIMENTAL
Intervention: General balanced anaesthesia
Number of subjects: 17
Study 1436561 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia
Number of subjects: 17
Study 6323866 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 4
Study 6323866 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 4
Study 6323866 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (CB-154)
Number of subjects: 4
Study 6323866 — intervention group
Group type: COMPARATOR
Intervention: Basal conditions (control)
Number of subjects: 4
Study 31491932 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Learning (E + L)
Number of subjects: 80
Study 31491932 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Only (L)
Number of subjects: 80
Study 31491932 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Only (E)
Number of subjects: 80
Study 31491932 — intervention group
Group type: COMPARATOR
Intervention: Control Group (C)
Number of subjects: 80
Study 29174765 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Control Treatment (ACT)
Number of subjects: 46
Study 29174765 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification Treatment (ABMT)
Number of subjects: 46
Study 29174765 — intervention group
Group type: COMPARATOR
Intervention: Both ACT and ABMT
Number of subjects: 46
Study 26638192 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Fat Diet (LF)
Number of subjects: 61
Study 26638192 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LC)
Number of subjects: 61
Study 24668700 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoids (Group A)
Number of subjects: 24
Study 24668700 — intervention group
Group type: COMPARATOR
Intervention: Control (Group B)
Number of subjects: 24
Study 22607043 — intervention group
Group type: EXPERIMENTAL
Intervention: V(10)-group (10% of ED(95) vecuronium)
Number of subjects: 100
Study 22607043 — intervention group
Group type: EXPERIMENTAL
Intervention: V(15)-group (15% of ED(95) vecuronium)
Number of subjects: 100
Study 22607043 — intervention group
Group type: EXPERIMENTAL
Intervention: V(20)-group (20% of ED(95) vecuronium)
Number of subjects: 100
Study 22607043 — intervention group
Group type: COMPARATOR
Intervention: V(0)-group (no priming)
Number of subjects: 100
Study 20513268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Schools (IS) - nutrition education and improvement of the food environment
Number of subjects: 659
Study 20513268 — intervention group
Group type: COMPARATOR
Intervention: Control Schools (CS)
Number of subjects: 659
Study 18407341 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (based on AUC of 7.5 and GFR from Jelliffe formula)
Number of subjects: 387
Study 15760685 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracardiac echocardiography (ICE)
Number of subjects: 80
Study 15760685 — intervention group
Group type: COMPARATOR
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 80
Study 12446070 — intervention group
Group type: EXPERIMENTAL
Intervention: CMR-determined graft flow and flow reserve
Number of subjects: 21
Study 12446070 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm combining basal volume flow <20 ml/min and graft flow reserve <2
Number of subjects: 21
Study 10100178 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose E2/NETA (2 mg E2/1 mg NETA)
Number of subjects: 54
Study 10100178 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose E2/NETA (1 mg E2/0.5 mg NETA)
Number of subjects: 54
Study 10100178 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 54
Study 8889353 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual MAP goal group (102-107 mm Hg)
Number of subjects: 94
Study 8889353 — intervention group
Group type: COMPARATOR
Intervention: Low MAP goal group (<= 92 mm Hg)
Number of subjects: 94
Study 8889353 — intervention group
Group type: COMPARATOR
Intervention: Enalapril drug regimen
Number of subjects: 94
Study 8889353 — intervention group
Group type: COMPARATOR
Intervention: Atenolol drug regimen
Number of subjects: 94
Study 8889353 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine drug regimen
Number of subjects: 94
Study 1905631 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in polyunsaturated fat (10% saturated fat, 9% monounsaturated fat, 18% polyunsaturated fat)
Number of subjects: 12
Study 1905631 — intervention group
Group type: COMPARATOR
Intervention: Diet rich in saturated fat (21% saturated fat, 12% monounsaturated fat, 3% polyunsaturated fat)
Number of subjects: 12
Study 7104149 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol, 100-300 mg/day
Number of subjects: 36
Study 7104149 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol, 5-15 mg/day
Number of subjects: 36
Study 30499837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MP (300 mg pregabalin orally + IV magnesium sulphate 50 mg/kg)
Number of subjects: 120
Study 30499837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group P (300 mg pregabalin orally + IV placebo)
Number of subjects: 120
Study 30499837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (IV magnesium sulphate 50 mg/kg + placebo capsule)
Number of subjects: 120
Study 30499837 — intervention group
Group type: COMPARATOR
Intervention: Group C (placebo capsule + IV placebo)
Number of subjects: 120
Study 30499837 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MP, P, M
Number of subjects: 120
Study 30650288 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinfeng Capsule (XFC), 3 pills each time, 3 times per day for 3 months
Number of subjects: 70
Study 30650288 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine, 1 pill each time, 3 times per day for 3 months
Number of subjects: 70
Study 26703477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular facet joint injections with local anaesthetic and steroids
Number of subjects: 150
Study 26703477 — intervention group
Group type: COMPARATOR
Intervention: Best usual care package with physical and psychological components
Number of subjects: 150
Study 24303967 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical P-wave morphology
Number of subjects: 892
Study 20022553 — intervention group
Group type: EXPERIMENTAL
Intervention: ZengShengPing (ZSP) - 4 tablets, 3 times per day for 8-12 months
Number of subjects: 59
Study 20022553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 20022553 — intervention group
Group type: EXPERIMENTAL
Intervention: ZengShengPing (ZSP) - 6g/kgBW/day by gavage for 10 weeks
Number of subjects: 59
Study 20022553 — intervention group
Group type: EXPERIMENTAL
Intervention: ZengShengPing (ZSP) - 10% in diet
Number of subjects: 59
Study 18154900 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (head cooling for 72 hours starting within 6 hours of birth, rectal temperature maintained at 34.5 degrees C ± 0.5 degrees C)
Number of subjects: 234
Study 18154900 — intervention group
Group type: COMPARATOR
Intervention: Standard care (maintained at 37.0 degrees C ± 0.5 degrees C)
Number of subjects: 234
Study 16279916 — intervention group
Group type: COMPARATOR
Intervention: Milk thistle (MT)
Number of subjects: 915
Study 12850615 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate pushing (n = 85)
Number of subjects: 202
Study 12850615 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed pushing (n = 117)
Number of subjects: 202
Study 10531164 — intervention group
Group type: EXPERIMENTAL
Intervention: Mode 1 (pressure variation from 4 to 15.5 cm H(2)O)
Number of subjects: 11
Study 10531164 — intervention group
Group type: EXPERIMENTAL
Intervention: Mode 2 (pressure variation from 4 cm H(2)O to individual upper limit)
Number of subjects: 11
Study 10531164 — intervention group
Group type: COMPARATOR
Intervention: Manual titrated nCPAP therapy
Number of subjects: 11
Study 8905934 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 3
Study 8905934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 3
Study 8905934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 1989572 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/d of oral haloperidol
Number of subjects: 87
Study 1989572 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/d of oral haloperidol
Number of subjects: 87
Study 1989572 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/d of oral haloperidol
Number of subjects: 87
Study 1989572 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 87
Study 6636033 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of fish oil (n-3 PUFA) for 4 weeks
Number of subjects: 0
Study 6636033 — intervention group
Group type: COMPARATOR
Intervention: 10 g of vegetable oil (n-6 PUFA) for 4 weeks
Number of subjects: 0
Study 30399034 — intervention group
Group type: EXPERIMENTAL
Intervention: CrAg screening and preemptive fluconazole therapy
Number of subjects: 3388
Study 30555398 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help book for insomnia (cognitive behavioral therapy for insomnia)
Number of subjects: 164
Study 30555398 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene advice
Number of subjects: 164
Study 25228440 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg lutein
Number of subjects: 112
Study 25228440 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg lutein
Number of subjects: 112
Study 25228440 — intervention group
Group type: EXPERIMENTAL
Intervention: lutein (10 mg) + zeaxanthin (10 mg)
Number of subjects: 112
Study 25228440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 22466015 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS group)
Number of subjects: 300
Study 22466015 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery (CON group)
Number of subjects: 300
Study 21316156 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpipe (WP)
Number of subjects: 61
Study 21316156 — intervention group
Group type: COMPARATOR
Intervention: Cigarettes
Number of subjects: 61
Study 19043656 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate therapy (with calcium 500 mg/day and cholecalciferol 250 IU/day)
Number of subjects: 1000
Study 19043656 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50% of participants)
Number of subjects: 1000
Study 17868862 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 0
Study 17868862 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 0
Study 14718892 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular abdominal aortic aneurysm repair (EVAR)
Number of subjects: 153
Study 14718892 — intervention group
Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 153
Study 11259687 — intervention group
Group type: COMPARATOR
Intervention: Statin drugs (HMG CoA reductase inhibitors)
Number of subjects: 46340
Study 9693477 — intervention group
Group type: EXPERIMENTAL
Intervention: Analyzing and reframing fashion advertisements (Intervention group)
Number of subjects: 105
Study 9693477 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (Control group)
Number of subjects: 105
Study 8848888 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 202
Study 8848888 — intervention group
Group type: COMPARATOR
Intervention: Epidural Anaesthesia (EA)
Number of subjects: 202
Study 1977438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cicloprolol 50 mg day‐1 with digoxin 0.25 mg day‐1
Number of subjects: 10
Study 1977438 — intervention group
Group type: COMPARATOR
Intervention: Placebo with digoxin 0.25 mg day‐1
Number of subjects: 10
Study 318680 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (15 mg)
Number of subjects: 20
Study 318680 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 20
Study 318680 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (125 to 500 mg)
Number of subjects: 20
Study 318680 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (after treatment with methylphenidate)
Number of subjects: 20
Study 318680 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (after treatment)
Number of subjects: 20
Study 30999963 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital signs triage intervention
Number of subjects: 2747
Study 23453011 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control (target blood glucose 120-160 mg/dl)
Number of subjects: 212
Study 23453011 — intervention group
Group type: COMPARATOR
Intervention: Control group (target blood glucose 161-200 mg/dl)
Number of subjects: 212
Study 21557031 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of primary care measured by provision of eight recommended preventive services
Number of subjects: 0
Study 21557031 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel Medicaid eligibility
Number of subjects: 0
Study 21557031 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery of influenza vaccine
Number of subjects: 0
Study 19234885 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 3 weeks
Number of subjects: 50
Study 19234885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 16519632 — intervention group
Group type: EXPERIMENTAL
Intervention: Marsupialization (M group)
Number of subjects: 46
Study 16519632 — intervention group
Group type: COMPARATOR
Intervention: Open wound (O group)
Number of subjects: 46
Study 12742557 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose COC (20 microg EE and 75 microg GTD) - Group A
Number of subjects: 56
Study 12742557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose COC (15 microg EE and 60 microg GTD) - Group B
Number of subjects: 56
Study 12742557 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls - Group C
Number of subjects: 56
Study 12742557 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, and C)
Number of subjects: 56
Study 10945963 — intervention group
Group type: EXPERIMENTAL
Intervention: ATLS group
Number of subjects: 32
Study 10945963 — intervention group
Group type: COMPARATOR
Intervention: Non-ATLS group
Number of subjects: 32
Study 8922571 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 10 mg/kg 1 x daily for 3 days
Number of subjects: 489
Study 8922571 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg 1 x daily for 3 days
Number of subjects: 489
Study 8922571 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V 125-250 mg 4 x daily for 10 days
Number of subjects: 489
Study 1375807 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation by nurses during pregnancy and continuing through at least the second year of the child's life
Number of subjects: 0
Study 1375807 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visitation programs that meet certain standards
Number of subjects: 0
Study 6690193 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In‐labelled heat damaged autologous erythrocytes (HD‐RBC)
Number of subjects: 26
Study 6690193 — intervention group
Group type: COMPARATOR
Intervention: 99mTc‐labelled erythrocytes (IgG‐RBC) coated with Rhesus anti‐D antibody (high coating)
Number of subjects: 26
Study 6690193 — intervention group
Group type: COMPARATOR
Intervention: 99mTc‐labelled erythrocytes (IgG‐RBC) coated with Rhesus anti‐D antibody (low coating)
Number of subjects: 26
Study 6690193 — intervention group
Group type: EXPERIMENTAL
Intervention: HD‐RBC
Number of subjects: 26
Study 6690193 — intervention group
Group type: EXPERIMENTAL
Intervention: Indium labelled platelets
Number of subjects: 26
Study 31706286 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal combination (420 mg proprietary blend of Urox®)
Number of subjects: 80
Study 31706286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 29031573 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized furosemide (40mg)
Number of subjects: 12
Study 29031573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 25968162 — intervention group
Group type: EXPERIMENTAL
Intervention: 980-nm diode laser with the power of 6-8 W
Number of subjects: 36
Study 25968162 — intervention group
Group type: COMPARATOR
Intervention: Traditional liposuction
Number of subjects: 36
Study 23962491 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Let Us Protect Our Future!' HIV/STD risk-reduction intervention
Number of subjects: 0
Study 23962491 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 0
Study 22751690 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 20
Study 20185637 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tolvaptan
Number of subjects: 111
Study 17646058 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐assisted tailored telephone counseling
Number of subjects: 2817
Study 17646058 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2817
Study 16322336 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment
Number of subjects: 88
Study 12077544 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% ketoconazole + 0.05% desonide gel (n = 9)
Number of subjects: 18
Study 12077544 — intervention group
Group type: COMPARATOR
Intervention: Unmedicated gel (placebo) (n = 9)
Number of subjects: 18
Study 9534557 — intervention group
Group type: EXPERIMENTAL
Intervention: Granuflex dressing
Number of subjects: 0
Study 9534557 — intervention group
Group type: COMPARATOR
Intervention: Spenco Dermal dressing
Number of subjects: 0
Study 8541695 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured-triglyceride (STG) emulsion
Number of subjects: 8
Study 8541695 — intervention group
Group type: COMPARATOR
Intervention: Long-chain fatty acid triglyceride (LCT; Intralipid 20%) emulsion
Number of subjects: 8
Study 8541695 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured-triglyceride (STG) emulsion (medium and high doses)
Number of subjects: 8
Study 8541695 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat infusion (STG and LCT)
Number of subjects: 8
Study 8541695 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups receiving STG and LCT emulsions
Number of subjects: 8
Study 1708118 — intervention group
Group type: EXPERIMENTAL
Intervention: Low power laser stimulation (904 nm infrared diode laser)
Number of subjects: 40
Study 1708118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 434583 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terbutaline (5 mg)
Number of subjects: 14
Study 434583 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous ingestion of terbutaline and Tedral
Number of subjects: 14
Study 434583 — intervention group
Group type: COMPARATOR
Intervention: Tedral
Number of subjects: 14
Study 31812554 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab at an initial dose of 2 mg/kg every 3 weeks
Number of subjects: 155
Study 31812554 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Number of subjects: 155
Study 31812554 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab in patients with solid tumours and other lymphomas
Number of subjects: 155
Study 31144672 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Guard app
Number of subjects: 58
Study 28439186 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in diabetes-related distress (n=79)
Number of subjects: 129
Study 28439186 — intervention group
Group type: COMPARATOR
Intervention: Worsening or unchanged diabetes distress (n=50)
Number of subjects: 129
Study 25845768 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 547
Study 25845768 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 547
Study 25845768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study 23379590 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (1500 mg-3000 mg)
Number of subjects: 258
Study 23379590 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 23379590 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 258